| |
|
|
| Name: |
TCG Crossover Management LLC |
| City: |
PALO ALTO |
| State: |
CA |
| Zip: |
94301 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
38 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
CGON |
CG Oncology, Inc |
1 |
- |
$26.00 |
$89,883,000 |
3,670,206 |
12.26% |
-15,379,000 |
0 |
5.561 |
N/A |
|
|
COGT |
Cogent Biosciences, Inc. |
2 |
- |
$7.18 |
$41,717,000 |
6,964,375 |
5.69% |
-12,605,000 |
0 |
5.339 |
N/A |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
3 |
- |
$0.00 |
$41,570,000 |
2,890,816 |
5.67% |
-6,851,000 |
0 |
2.207 |
N/A |
|
|
MLYS |
Mineralys Therapeutics, Inc. |
4 |
- |
$0.00 |
$39,228,000 |
2,470,265 |
5.35% |
8,819,000 |
0 |
4.967 |
N/A |
|
|
OCUL |
Ocular Therapeutix, Inc |
5 |
- |
$0.00 |
$38,989,000 |
5,319,148 |
5.32% |
-6,437,000 |
0 |
3.411 |
N/A |
|
|
ABVX |
Abivax S.A |
6 |
- |
$7.65 |
$37,854,000 |
6,056,596 |
5.16% |
-6,480,000 |
0 |
9.769 |
N/A |
|
|
SVRA |
Savara Inc |
7 |
- |
$2.28 |
$34,243,000 |
12,362,205 |
4.67% |
-3,709,000 |
0 |
7.51 |
Biotechnology |
|
|
DYN |
Dyne Therapeutics, Inc. |
8 |
- |
$9.52 |
$27,721,000 |
2,650,150 |
3.78% |
-34,717,000 |
0 |
2.296 |
N/A |
|
|
DNTH |
Dianthus Therapeutics Ord Shs |
9 |
- |
$0.70 |
$27,239,000 |
1,501,624 |
3.72% |
-5,496,000 |
0 |
4.62 |
N/A |
|
|
TYRA |
Tyra Biosciences, Inc. |
10 |
- |
$0.00 |
$26,952,000 |
2,898,103 |
3.68% |
-697,000 |
909,000 |
5.495 |
N/A |
|
|
XNCR |
Xencor Inc |
11 |
- |
$7.86 |
$26,091,000 |
2,452,138 |
3.56% |
-30,259,000 |
0 |
2.725 |
Biotechnology |
|
|
IRON |
Disc Medicine, Inc |
12 |
- |
$52.96 |
$23,095,000 |
465,257 |
3.15% |
-7,778,000 |
-21,700 |
1.565 |
N/A |
|
|
TRML |
Tourmaline Bio |
13 |
- |
$0.00 |
$22,474,000 |
1,477,593 |
3.07% |
-7,492,000 |
0 |
3.577 |
N/A |
|
|
CDTX |
Cidara Therapeutics, Inc. |
14 |
- |
$48.71 |
$21,667,000 |
1,005,901 |
2.96% |
-4,425,000 |
0 |
22.054 |
N/A |
|
|
AMLX |
Amylyx Pharmaceuticals, Inc. |
15 |
- |
$0.00 |
$21,041,000 |
5,943,812 |
2.87% |
3,487,000 |
1,300,000 |
8.803 |
N/A |
|
|
SLNO |
Soleno Therapeutics Inc |
16 |
- |
$0.16 |
$19,649,000 |
275,000 |
2.68% |
-5,074,000 |
-275,000 |
0.345 |
N/A |
|
|
EYPT |
EyePoint Pharmaceuticals Inc |
17 |
- |
$0.44 |
$19,362,000 |
3,572,335 |
2.64% |
-7,252,000 |
0 |
2.489 |
Biotechnology |
|
|
GPCR |
Structure Therapeutics Inc. |
18 |
- |
$20.74 |
$18,401,000 |
1,063,000 |
2.51% |
-10,428,000 |
0 |
1.687 |
N/A |
|
|
UPB |
Upstream Bio, Inc. |
19 |
- |
$10.98 |
$17,147,000 |
2,801,763 |
2.34% |
-27,709,000 |
0 |
5.286 |
N/A |
|
|
RAPT |
Rapt Therapeutics, Inc. |
20 |
- |
$1.03 |
$15,970,000 |
13,090,200 |
2.18% |
-3,781,000 |
-45,060 |
36.254 |
N/A |
|
|
FULC |
Fulcrum Therapeutics, Inc. |
21 |
- |
$0.00 |
$15,120,000 |
5,250,000 |
2.06% |
-9,555,000 |
0 |
5.553 |
N/A |
|
|
ATXS |
Astria Therapeutics, Inc |
22 |
- |
$5.36 |
$14,748,000 |
2,761,861 |
2.01% |
-9,943,000 |
0 |
4.661 |
N/A |
|
|
TNGX |
Tango Therapeutics Ord Shs |
23 |
- |
$0.00 |
$14,708,000 |
10,736,000 |
2.01% |
-18,466,000 |
0 |
10.527 |
N/A |
|
|
CMPS |
Compass Pathways Plc |
24 |
- |
$0.00 |
$11,034,000 |
3,858,000 |
1.51% |
-3,549,000 |
0 |
11.083 |
N/A |
|
|
KURA |
Kura Oncology Inc |
25 |
- |
$5.77 |
$9,396,000 |
1,423,642 |
1.28% |
-3,004,000 |
0 |
1.7 |
N/A |
|
|
THRD |
Third Harmonic Bio, Inc. |
26 |
- |
$5.43 |
$8,694,000 |
2,505,424 |
1.19% |
-17,087,000 |
0 |
5.568 |
N/A |
|
|
SLN |
Silence Therapeutics Adr Re... |
27 |
- |
$0.00 |
$8,555,000 |
3,033,560 |
1.17% |
-12,316,000 |
0 |
10.176 |
N/A |
|
|
ADVM |
Adverum Biotechnologies, Inc |
28 |
- |
$2.15 |
$7,851,000 |
1,796,482 |
1.07% |
-539,000 |
0 |
1.779 |
N/A |
|
|
VTGN |
Vistagen Therapeutics Inc |
29 |
- |
$2.00 |
$6,691,000 |
2,676,580 |
0.91% |
-1,205,000 |
0 |
9.902 |
Biotechnology |
|
|
JBIO |
Jade Biosciences |
30 |
- |
$0.00 |
$5,624,000 |
2,240,809 |
0.77% |
-314,000 |
0 |
8.098 |
N/A |
|
|
TRDA |
Entrada Therapeutics, Inc. |
31 |
- |
$0.00 |
$5,288,000 |
584,955 |
0.72% |
-4,826,000 |
0 |
1.874 |
N/A |
|
|
MBX |
Mbx Biosciences, Inc. |
32 |
- |
$0.00 |
$4,797,000 |
650,000 |
0.65% |
-7,183,000 |
0 |
1.945 |
N/A |
|
|
AVTX |
Avalo Therapeutics, Inc |
33 |
- |
$0.43 |
$3,869,000 |
483,000 |
0.53% |
280,000 |
0 |
0.43 |
N/A |
|
|
KOD |
Kodiak Sciences Inc. |
34 |
- |
$3.73 |
$3,213,000 |
1,145,538 |
0.44% |
-8,185,000 |
0 |
2.557 |
N/A |
|
|
NKTR |
Nektar Therapeutics |
35 |
- |
$0.67 |
$2,720,000 |
4,000,000 |
0.37% |
-1,000,000 |
0 |
2.23 |
Drug Delivery |
|
|
VTYX |
Ventyx Biosciences, Inc. |
36 |
- |
$2.14 |
$364,000 |
316,195 |
0.05% |
-328,000 |
0 |
0.447 |
N/A |
|
|
CABA |
Cabaletta Bio, Inc. |
37 |
- |
$0.00 |
$120,000 |
86,795 |
0.02% |
-77,000 |
0 |
0.169 |
N/A |
|
|
KROS |
Keros Therapeutics, Inc. |
38 |
- |
$0.00 |
$0 |
0 |
0% |
-8,707,000 |
-550,000 |
0 |
N/A |
|
